The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Kerr, MD
ASCLEPES Research Centers
Principal Investigator - Don Stevens, MD
Norton Cancer Institute
Principal Investigator - Elizabeth Budde, MD
City of Hope Medical Center
Principal Investigator - Lasika Seneviratne, MD
Los Angeles Cancer Network
Principal Investigator - Nashat Gabrail, MD
Gabrail Cancer Center Research
Principal Investigator - Pamela Miel, MD
Innovative Clinical Research Institute
Principal Investigator - Paul Rubinstein, MD
University of Illinois at Chicago
Principal Investigator - Salil Goorha, MD
Memphis Baptist Cancer Center
Principal Investigator - Stefano Tarantolo, MD
Nebraska Cancer Specialists
Principal Investigator - Tamra Slone, MD
U Texas SouthWestern
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
Elizabeth BuddeRecruiting - Los Angeles Cancer Network
Los Angeles, California, United States
Lasika SeneviratneRecruiting - Ucla Medical Center of Hematology/oncology
Los Angeles, California, United States
Gary J SchillerRecruiting - Innovative Clinical Research Institute
Whittier, California, United States
Recruiting - Asclepes Research Centers
Weeki Wachee, Florida, United States
Recruiting - University of Illinois at Chicago Cancer Center
Chicago, Illinois, United States
Recruiting - Norton Cancer Institute
Louisville, Kentucky, United States
Don Stevens, MDRecruiting - Oncology Hematology West P.C. Dba Nebraska Cancer Specialists
Omaha, Nebraska, United States
Ryan Ramaekers, MDStefano Tarantolo, MDRecruiting - Gabrail Cancer Center Research,
Canton, Ohio, United States
Recruiting - Baptist Clinical Research Institute
Memphis, Tennessee, United States
Salil GoorhaRecruiting - University of Texas(ut) Southwestern-Children'S Medical Center
Dallas, Texas, United States
Slone TamraRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Nov 2020
- Primary completion
- 30 Nov 2027
- Completion
- 1 Dec 2028
- Last update posted
- 15 Apr 2026
- Registered enrollment
- 144
- Registry id
- NCT04329728
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.